Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 4 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Medium-Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway.
Adv Sci (Weinh). 2024 Apr;11(15):e2306232. doi: 10.1002/advs.202306232. Epub 2024 Feb 14.
Adv Sci (Weinh). 2024.
PMID: 38353392
Free PMC article.
Sex differences in the management of patients with suspected acute coronary syndrome in China.
Cheng K, Wang J, Zheng W, Wu S, Zheng J, Sang W, Ma J, Pang J, Pan C, Wang G, Wu Y, Chen Y, Xu F.
Cheng K, et al.
Intern Emerg Med. 2023 Dec 16. doi: 10.1007/s11739-023-03494-3. Online ahead of print.
Intern Emerg Med. 2023.
PMID: 38102447
Item in Clipboard
NKRF in Cardiac Fibroblasts Protects against Cardiac Remodeling Post-Myocardial Infarction via Human Antigen R.
Guo C, Ji W, Yang W, Deng Q, Zheng T, Wang Z, Sui W, Zhai C, Yu F, Xi B, Yu X, Xu F, Zhang Q, Zhang W, Kong J, Zhang M, Zhang C.
Guo C, et al.
Adv Sci (Weinh). 2023 Oct;10(30):e2303283. doi: 10.1002/advs.202303283. Epub 2023 Sep 5.
Adv Sci (Weinh). 2023.
PMID: 37667861
Free PMC article.
NKRF inhibits CF migration and invasion in vitro by downregulating MMP2 and MMP9 expression. Mechanistically, NKRF inhibits human antigen R (HuR) transcription by binding to the classical negative regulatory element within the HuR promoter via an NF-kappaB-dependent mechan …
NKRF inhibits CF migration and invasion in vitro by downregulating MMP2 and MMP9 expression. Mechanistically, NKRF inhibits human antigen …
Item in Clipboard
Deubiquitinase OTUD5 as a Novel Protector against 4-HNE-Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury.
Liu L, Pang J, Qin D, Li R, Zou D, Chi K, Wu W, Rui H, Yu H, Zhu W, Liu K, Wu X, Wang J, Xu P, Song X, Cao Y, Wang J, Xu F, Xue L, Chen Y.
Liu L, et al.
Adv Sci (Weinh). 2023 Oct;10(28):e2301852. doi: 10.1002/advs.202301852. Epub 2023 Aug 8.
Adv Sci (Weinh). 2023.
PMID: 37552043
Free PMC article.
Despite the development of advanced technologies for interventional coronary reperfusion after myocardial infarction, a substantial number of patients experience high mortality due to myocardial ischemia-reperfusion (MI/R) injury. An in-depth understanding of the mechanism …
Despite the development of advanced technologies for interventional coronary reperfusion after myocardial infarction, a substantial number o …
Item in Clipboard
[Safety and efficacy of the early administration of levosimendan in patients with acute non-ST-segment elevation myocardial infarction and elevated NT-proBNP levels: An Early Management Strategy of Acute Heart Failure (EMS-AHF)].
Xu F, Bian Y, Zhang GQ, Gao LY, Liu YF, Liu TX, Li G, Song RX, Su LJ, Zhou YJ, Cui JY, Yan XL, Guo FM, Zhang HY, Li QH, Zhao M, Ma LK, You BA, Wang G, Kong L, Ma JL, Zhou XF, Chang ZL, Tang ZY, Yu DY, Cheng K, Xue L, Li X, Pang JJ, Wang JL, Zhang HT, Yu XZ, Chen YG.
Xu F, et al.
Zhonghua Nei Ke Za Zhi. 2023 Apr 1;62(4):374-383. doi: 10.3760/cma.j.cn112138-20220420-00284.
Zhonghua Nei Ke Za Zhi. 2023.
PMID: 37032132
Clinical Trial.
Chinese.
Item in Clipboard
Cite
Cite